99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis

Anticancer Res. 2004 May-Jun;24(3b):1999-2006.

Abstract

Background: Vascular endothelial growth factor (VEGF) is a prognostic factor in breast cancer. One of the mechanisms of extra-skeletal uptake of Tc-99m-methylenediphosphonate (MDP) is suggested to be tumor vascularity. We studied the correlation between MDP uptake and VEGF and compared the diagnostic accuracy of mammography versus MDP-scintimammography (MDP-S).

Materials and methods: Fifty-four patients with suspicion of breast cancer were evaluated. Breast images were collected 5-10 minutes after injection of Tc-99m-MDP prior to biopsy. Tissue slides were stained using a rabbit-polyclonal anti-VEGF.

Results: MDP-S showed a diagnostic accuracy of 83.3% in BIRADS category 4 lesions. Four out of 23 benign lesions were false-positive. The tumor to background (TM/BG) ratio of early images of MDP-S was correlated with VEGF staining (p: 0.014) and with tumor size (p: 0.006).

Conclusion: Early images of Tc-99m-MDP-S may satisfactorily identify cancers with increased neovascularization. MDP-S seems to be an accurate imaging modality, especially in BIRADS category 4 lesions.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / blood supply*
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / metabolism
  • Female
  • Humans
  • Mammography / methods
  • Middle Aged
  • Neovascularization, Pathologic / diagnostic imaging*
  • Neovascularization, Pathologic / metabolism
  • Radionuclide Imaging
  • Radiopharmaceuticals* / pharmacokinetics
  • Technetium Tc 99m Medronate* / pharmacokinetics
  • Vascular Endothelial Growth Factor A / analysis

Substances

  • Radiopharmaceuticals
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Technetium Tc 99m Medronate